Growth factors for diabetic foot ulcers: mixed treatment comparison analysis of randomized clinical trials
K Sridharan, G Sivaramakrishnan - British journal of clinical …, 2018 - Wiley Online Library
… Also, head-to-head comparison using various growth factors in the management of DFU … is
the first evidence comparing the efficacies and safety of various growth factors, albeit indirectly…
the first evidence comparing the efficacies and safety of various growth factors, albeit indirectly…
Efficacy and Safety of Anti–Vascular Endothelial Growth Factor Monotherapies for Neovascular Age-Related Macular Degeneration: A Mixed Treatment Comparison
Y Zhang, S Gao, X Li, X Huang, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
… efficacy and safety of anti–vascular endothelial growth factor (… randomized controlled trials
comparing the recommended … regimens had better visual efficacy. Brolucizumab had absolute …
comparing the recommended … regimens had better visual efficacy. Brolucizumab had absolute …
Randomized placebo‐controlled and controlled non‐inferiority phase III trials comparing trafermin, a recombinant human fibroblast growth factor 2, and enamel matrix …
M Kitamura, M Akamatsu, M Kawanami… - Journal of Bone and …, 2016 - academic.oup.com
… We investigated the efficacy, safety, and clinical significance of trafermin, a recombinant
human fibroblast growth factor (rhFGF)‐2, for periodontal regeneration in intrabony defects in …
human fibroblast growth factor (rhFGF)‐2, for periodontal regeneration in intrabony defects in …
Efficacy and safety of becaplermin (recombinant human platelet‐derived growth factor‐BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined …
JM Smiell, TJ Wieman, DL Steed… - Wound Repair and …, 1999 - Wiley Online Library
… the results of the 4 individual studies to more precisely assess the relative efficacies of 4
treatment regimens, with a focus on the comparison of becaplermin gel at a dose of 100 μg/g vs. …
treatment regimens, with a focus on the comparison of becaplermin gel at a dose of 100 μg/g vs. …
Comparison of the efficacy of gefitinib in patients with non-small cell lung cancer according to the type of epidermal growth factor receptor mutation
S Igawa, M Kasajima, M Ishihara, M Kimura, Y Hiyoshi… - Oncology, 2014 - karger.com
Background: Exon 19 deletion and L858R point mutation of the epidermal growth factor
receptor (EGFR) are the most commonly encountered EGFR mutations in non-small cell lung …
receptor (EGFR) are the most commonly encountered EGFR mutations in non-small cell lung …
Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously …
S Noda-Narita, A Shimomura, A Kawachi… - Breast Cancer, 2019 - Springer
… for patients with human epidermal growth factor receptor 2 (HER2… efficacy of T-DM1 in those
who have previously received pertuzumab (Pmab). This study aimed to compare the efficacy …
who have previously received pertuzumab (Pmab). This study aimed to compare the efficacy …
Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell …
N Aiko, T Shimokawa, K Miyazaki, Y Misumi, Y Agemi… - BMC cancer, 2018 - Springer
… Compared with standard chemotherapy, epidermal growth factor … However, data comparing
the efficacies of different EGFR−TKIs, … epidermal growth factor receptor (EGFR) mutations [2]. …
the efficacies of different EGFR−TKIs, … epidermal growth factor receptor (EGFR) mutations [2]. …
Comparisons of Cytokines, Growth Factors and Clinical Efficacy between Platelet-Rich Plasma and Autologous Conditioned Serum for Knee Osteoarthritis …
PG Cheng, KD Yang, LG Huang, CH Wang, WS Ko - Biomolecules, 2023 - mdpi.com
… growth factors we performed in the present study may provide the opportunity for subjective
comparisons… the anti-inflammatory mediator and growth factors between both groups. Further …
comparisons… the anti-inflammatory mediator and growth factors between both groups. Further …
The efficacy of nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: a meta-analysis
S Yang, Y Huang, Z Ye, L Li, Y Zhang - Frontiers in Pharmacology, 2020 - frontiersin.org
… Background: Nerve growth factor (NGF) plays a crucial role in pain modulation and is being
… The purpose of this meta-analysis was to study the efficacy of anti-NGF antibodies for the …
… The purpose of this meta-analysis was to study the efficacy of anti-NGF antibodies for the …
Efficacy and safety of nerve growth factor for the treatment of neurological diseases: a meta-analysis of 64 randomized controlled trials involving 6,297 patients
M Zhao, X Li, C Xu, L Zou - Neural regeneration research, 2015 - journals.lww.com
… growth factor is approved for large-scale use as a clinical medicine. More than 10 years ago,
in 2003, nerve growth factor … controlled trials of nerve growth factor during the past ten years …
in 2003, nerve growth factor … controlled trials of nerve growth factor during the past ten years …
相关搜索
- comparative efficacy growth factor therapy
- safety and efficacy growth factor therapies
- nerve growth factor
- growth factor meta analysis
- growth factors diabetic foot ulcers
- growth factor receptor
- epidermal growth factor receptor gene mutations
- fibroblast growth factor
- epidermal growth factor receptor exon
- growth factor brain metastasis
- growth factor non-small cell lung cancer
- growth factor breast cancer
- growth factor systematic review
- growth factor macular degeneration
- system efficacy epidermal growth factor
- network meta analysis growth factor therapy